-
2023-510099-30-00
5
2025-09-23
Out-of-hospital cardiac arrest with initial shockable rhythm
-
2024-511663-28-00
6
2025-09-11
Asymptomatic Child-Pugh A5 to B8 cirrhosis
-
2024-517167-23-00
5
2025-08-28
Chronic Hepatitis D Infection
-
2024-515884-69-00
5
2025-07-16
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
-
2023-504831-42-00
5
2025-06-27
patient with colorectal cancer with hepatic metastasis
-
2023-510262-27-00
4
2025-06-24
newly diagnosed or relapsing deep venous thrombosis related to Behçet’
-
2024-517457-27-00
5
2025-06-04
Chronic Obstructive Pulmonary Disease (COPD)
-
2024-519116-14-00
4
2025-05-27
Asthma
-
2023-509547-27-00
5
2025-05-22
Geographic Atrophy Secondary to Age-Related Macular Degeneration
-
2024-510589-17-00
7
2025-05-09
Healthy volunteers
-
2023-506512-40-00
5
2025-04-16
Acute Kidney Injury
-
2023-506601-19-00
6
2025-04-15
transplantation
-
2024-517582-16-00
5
2025-04-14
rapid sequence induction in the operating room
-
2023-504086-23-00
5
2025-03-27
Subjects with PBC with a non-optimal response to UDCA.
-
2024-514804-14-00
6
2025-03-26
Liver transplantation
-
2023-503326-39-00
5
2025-03-06
Synchronous oligometastatic non-small cell lung cancer (NSCLC)
-
2024-512442-41-00
9
2024-12-03
Colorectal Carcinoma, Biliary Tract Carcinoma, Hepatocellular Carcinom
-
2024-512895-36-00
5
2024-11-25
Non Alcoholic Steatohepatitis (NASH)
-
2023-509912-27-00
5
2024-11-07
Metabolic Dysfunction-Associated Steatotic Liver Disease(MASH) / Nonal
-
2022-502972-22-00
5
2024-10-31
Clostridioides difficile infection.
-
2023-510395-31-00
5
2024-10-30
Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Compensat
-
2023-509340-10-00
5
2024-10-29
Patients with HLA-A2 positive phenotype and metastatic Non-Small Cell
-
2024-516101-23-00
5
2024-10-28
Sarcoidosis
-
2023-504755-26-00
4
2024-10-21
Bronchiectasis